GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 817 filers reported holding GLAXOSMITHKLINE PLC in Q3 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $13,143,000 | -4.7% | 301,954 | -4.7% | 0.02% | +9.1% |
| Q1 2022 | $13,796,000 | -0.7% | 316,722 | +0.6% | 0.02% | +4.8% |
| Q4 2021 | $13,888,000 | +18.7% | 314,944 | +2.9% | 0.02% | +10.5% |
| Q3 2021 | $11,698,000 | +12.3% | 306,136 | +17.0% | 0.02% | +11.8% |
| Q2 2021 | $10,414,000 | +25.1% | 261,544 | +12.1% | 0.02% | +21.4% |
| Q1 2021 | $8,323,000 | -35.8% | 233,234 | -33.8% | 0.01% | -44.0% |
| Q4 2020 | $12,956,000 | -54.0% | 352,072 | -52.9% | 0.02% | -59.7% |
| Q3 2020 | $28,145,000 | -18.0% | 747,752 | -11.2% | 0.06% | -19.5% |
| Q2 2020 | $34,342,000 | -3.5% | 841,926 | -10.3% | 0.08% | -18.1% |
| Q1 2020 | $35,579,000 | -25.3% | 939,025 | -7.3% | 0.09% | -3.1% |
| Q4 2019 | $47,616,000 | +546.5% | 1,013,329 | +487.3% | 0.10% | -23.0% |
| Q3 2019 | $7,365,000 | +6.2% | 172,551 | -0.5% | 0.13% | +5.0% |
| Q2 2019 | $6,938,000 | -6.3% | 173,356 | -2.1% | 0.12% | -9.1% |
| Q1 2019 | $7,401,000 | +4.5% | 177,099 | -4.5% | 0.13% | -9.0% |
| Q4 2018 | $7,083,000 | -14.4% | 185,381 | -10.0% | 0.14% | -2.7% |
| Q3 2018 | $8,278,000 | -4.1% | 206,090 | -3.8% | 0.15% | -9.1% |
| Q2 2018 | $8,633,000 | +7.1% | 214,163 | +3.8% | 0.16% | +6.5% |
| Q1 2018 | $8,062,000 | +22.4% | 206,360 | +11.2% | 0.15% | +25.2% |
| Q4 2017 | $6,585,000 | -21.3% | 185,654 | -9.9% | 0.12% | -24.1% |
| Q3 2017 | $8,362,000 | +0.3% | 205,965 | +6.5% | 0.16% | -1.8% |
| Q2 2017 | $8,339,000 | +2.1% | 193,387 | -0.2% | 0.16% | +0.6% |
| Q1 2017 | $8,171,000 | -8.8% | 193,806 | -16.7% | 0.16% | -10.4% |
| Q4 2016 | $8,960,000 | -18.2% | 232,671 | -8.3% | 0.18% | -18.7% |
| Q3 2016 | $10,948,000 | -1.0% | 253,837 | -0.6% | 0.22% | -3.0% |
| Q2 2016 | $11,063,000 | +24.8% | 255,256 | +16.8% | 0.23% | +1.3% |
| Q1 2016 | $8,863,000 | +6.1% | 218,569 | +5.6% | 0.23% | +5.5% |
| Q4 2015 | $8,352,000 | +2.9% | 206,978 | -2.0% | 0.22% | +2.8% |
| Q3 2015 | $8,120,000 | +3.0% | 211,182 | +11.6% | 0.21% | -0.9% |
| Q2 2015 | $7,881,000 | +0.3% | 189,219 | +11.1% | 0.21% | -5.8% |
| Q1 2015 | $7,857,000 | +45.5% | 170,248 | +34.8% | 0.23% | +43.0% |
| Q4 2014 | $5,400,000 | +38.4% | 126,327 | +48.9% | 0.16% | +33.9% |
| Q3 2014 | $3,901,000 | -12.0% | 84,859 | +2.4% | 0.12% | -11.3% |
| Q2 2014 | $4,432,000 | +3.9% | 82,871 | +3.9% | 0.13% | -0.7% |
| Q1 2014 | $4,264,000 | -0.5% | 79,796 | -0.6% | 0.13% | -2.9% |
| Q4 2013 | $4,286,000 | +7.0% | 80,259 | +0.5% | 0.14% | -2.8% |
| Q3 2013 | $4,007,000 | -3.1% | 79,873 | -3.5% | 0.14% | -7.8% |
| Q2 2013 | $4,136,000 | – | 82,776 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |